The authors examined cancer incidence sex ratios in Denmark for 1943-2003 by age group. At nongenital/ nonbreast sites, incidences were consistently higher in males. While environmental factors dominate cancer risk, the authors hypothesized that the higher risk in males might be explained by unspecified X chromosome genes' protecting female cells from genotoxic damage. If so, cancer susceptibility would be passed from parent to offspring differently by sex. The authors compared relative risks in offspring of parents with and without cancer histories. For all comparisons, relative risks were similar in offspring of fathers with cancer (relative risk (RR) ¼ 1.14, 95% confidence interval: 1.08, 1.20). Risks in offspring were higher for parents diagnosed before age 50 years and for cancers at the same site rather than different sites. Genital cancer risks were increased in same-sex offspring of parents with genital cancers. Breast cancer risks were high in both daughters (RR ¼ 2.37) and sons (RR ¼ 4.63) of mothers with breast cancer and in daughters (RR ¼ 5.96) of fathers with breast cancer. Thus, X chromosome genetic factors were not responsible for the excess risk of cancer in males. Susceptibility to genital cancer was increased in same-sex offspring, and breast cancer risks were increased in both sons and daughters when either parent had had breast cancer.
Cancer risk is generally higher in men than in women at organ sites that both sexes have in common (i.e., not the breast and genital organs). The usual explanation for the male excess is variation in environmental exposures, such as smoking, diet, and occupation. While environmental exposures dominate cancer risk, environmental variations alone are not parsimonious explanations for the difference in cancer risk between the sexes. Such an explanation would require differences in environmental exposures for each of these cancers. Furthermore, such exposures must explain the male excess in young adults and perhaps even in children, who have little cumulative exposure to environmental genotoxins.
At the cellular level, genetic errors underlie cancer risk. Therefore, a potential explanation for the increased male cancer risk is that males cope with similar levels of genotoxic exposure less effectively than females. Hypothetically, constitutive genetic differences by sex could affect the accumulation of genetic damage, and hence cancer risk might be mediated through many routes, such as variation in the metabolism of hazardous compounds or the handling of oxidative stress, repair of DNA damage, or failure of apoptosis pathways to eliminate potentially abnormal cells. In a recent report, inactivation of the X chromosome was found to be skewed in carriers of the breast cancer 1 (BRCA1) mutation and possibly carriers of the breast cancer 2 (BRCA2) mutation in a way which protects against the development of breast cancer (1) .
We hypothesized that an increased susceptibility to cancer related to the X chromosome might be 1 component of the increased male cancer risk. For example, when using Entrez (2) to search the National Center for Biotechnology Information database for X chromosome genes with any annotation or references associating them with a cancer phenotype, 159 genes are returned. We identified at least 9 genes located only on the X chromosome that function in DNA repair: APEX2, ATRX, CUL4B, FANCB, MORF4L2, NONO, POLA1, SMC1A, and TREX. Similarly, 17 X chromosome genes with a Gene Ontology annotation of apoptosis were found: AGTR2, AIFM1, ARHGEF6, BCAP31, BTK, CD40LG, GSPT2, IKBKG, MAGED1, MAGEH1, NGFRAP1, PIM2, RP6-213H19.1, SH3KBP1, SLC25A6, SPIN2B, and XIAP.
With only a single X chromosome, all cells in a male must depend on the alleles of the maternally inherited X chromosome. Cells in females have 2 X chromosomes. However, because of the phenomenon of random X chromosome inactivation in a female, usually genes from only 1 X chromosome are transcribed in each cell (with exceptions at specific genes) (3). In females, approximately 50% of the cells express maternal X alleles and 50% express paternal X alleles, so half of a female's cells depend on paternal X alleles (3) . Assuming that the generally greater risk in males were conveyed in part by the X chromosome, males inheriting the risk allele from their mothers could have an increased incidence of cancer compared with females who inherited this allele from their fathers, because only half of the daughters' cells would rely on the paternal X chromosome. Such susceptibility to genotoxic damage might help to explain part of the approximately 50% excess risk of cancer in men compared with women for organs that are present in both sexes.
We reasoned that if part of cancer susceptibility were X-chromosome-related, fathers with cancer would pass this X-chromosome-related susceptibility on to all of their daughters, half of whose cells would depend on the paternal X chromosome (assuming that X chromosome inactivation were random). In contrast, sons would have no such X-chromosome-related susceptibility from their fathers, because they do not inherit the X chromosome from their fathers. Thus, cancer risks might differ between sons and daughters of fathers with cancer. To evaluate this hypothesis, we examined cancer risks in offspring of parents with cancer, comparing them with the risks in offspring of parents without cancer.
MATERIALS AND METHODS
To examine cancer incidence ratios by sex, we used data from the Danish Cancer Registry. Cancer diagnoses have been systematically recorded in the Danish Cancer Registry since 1943 (4) . In this analysis, we used information entered into the Registry from 1943 through emigration, death, or the end of the study period (December 2003). All types of cancers were included except nonmelanoma skin cancers and sex-specific cancers at genital sites (cancers of the prostate, testis, and penis/scrotum for men and cancers of the uterus/cervix, ovary, and vulva/vagina for women). Although breast cancer can occur in men, it was not included in our sex ratio evaluations because of the much higher incidence of breast cancer in women than in men. Similar analyses were performed on incidence data obtained from the US National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) Registry (5) for data from 1973 through 2000. The Danish and US data showed very similar patterns of male excess; therefore, only Danish data are presented in detail.
Since April 2, 1968, Denmark's Civil Registration System has given all residents of Denmark personal identity numbers through which parents and offspring can be linked. Almost all children under age 18 years would have been living at home in 1968, permitting the construction of the Danish Family Relations Database (6) , which provided reliable parentoffspring linkages from 1950 onward. Our final cohort was based on offspring born since 1950 who were linked to at least 1 identified parent and consisted of 3,483,569 individuals linked to parents. Links to mothers and fathers were identified in 99.7% and 98.0% of offspring, respectively. Each family was a nuclear unit, and thus a subject in the offspring cohort could also be a parent in a later generation. Linkages were based on legal parenthood; thus, misidentified paternity or adoption would result in erroneous linkage and a conservative estimate. Data use was approved by Danish ethical review boards and the Danish Data Protection Agency.
Incidence rate ratios have been presented here as relative risks and 95% confidence intervals. Male:female cancer incidence ratios were compared by site in different age groups and overall, after adjustment for age and calendar period in 5-year intervals. In analyses of offspring risks, relative risks compared cancer risks in sons and daughters of parents with and without a family history of cancer. Estimates were made by log-linear Poisson regression (7) using the PROC GENMOD procedure in SAS (version 9.1; SAS Institute Inc., Cary, North Carolina), with adjustment for age and calendar period in 5-year intervals. Relative risks compare cancer rates in offspring with rates within the same general cancer group (e.g., all cancers, nongenital/nonbreast cancers, genital cancers, and breast cancers) in the parent. Parental history of cancer was treated as a time-fixed variable, so cancer in the parent at any age was a flag used to identify the parent as potentially conveying a genetic risk to the offspring. Most offspring were under 50 years of age (maximum age, 53 years). To make parental and offspring cancer experiences comparable by age, in secondary analyses we examined risks among offspring by parental age at first diagnosis of cancer (<50 years vs. 50 years) in each specified category.
RESULTS

Cancer incidence sex ratios
In Danish adults, excluding genital and breast cancer, the relative risks of cancer in males compared with females increased with age, being 1.05 (95% confidence interval (CI): 1.03, 1.07), 1.64 (95% CI: 1.63, 1.65), and 1.83 (95% CI: 1.81, 1.84) among persons aged 15-49, 50-69, and 70 years, respectively (Table 1 ). In children under age 15 years, the male:female sex ratio was 1.17 (95% CI: 1.10, 1.23). Similar excesses in males of all ages were also observed in US SEER data (data not shown); relative risks were 1.1, 1.3, 2.0, and 2.1 for persons aged <15, 15-49, 50-69, and 70 years, respectively, with each of these higher risks in males being statistically significant, including risks among children. In both Danish and US adults, significant male excesses occurred at almost every specific site in all age groups. Exceptions were seen for thyroid and gallbladder cancer, for which higher rates were observed in females at all ages. Regarding cutaneous melanoma, the sex ratio favored women among young persons but men among older persons. The low cancer rate in childhood resulted in unstable sex ratios at specific sites; but overall, the significantly higher relative risks in males were driven largely by the male predominance in the incidences of leukemia and lymphoma, which are the most common types of cancer in childhood.
Familial cancer risks
The study population included 1,664,131 daughters and 1,819,380 sons of parents in Denmark, of whom 540,838 (15.5%) had at least 1 parent with a history of cancer, including 300,179 mothers and 292,417 fathers. For 49,571 (1.4%) offspring, both parents had cancer histories.
For all cancer types, fathers with cancer had 2,840 sons and 3,161 daughters who developed cancer ( Table 2 ). The relative risks of all cancer in the sons and daughters of fathers with cancer compared with those without cancer histories were 1.14 (95% CI: 1.09, 1.19) and 1.16 (95% CI: 1.11, 1.20), respectively. Overall, more cancers occurred in daughters because of the high incidence of genital and breast cancers, which often occur in women under age 50 years. Excluding genital and breast cancers in fathers and their offspring, fathers with cancer had 1,794 sons and 1,355 daughters who developed cancer. The relative risks were 1.14 (95% CI: 1.08, 1.20) and 1.14 (95% CI: 1.08, 1.21) in sons and daughters, respectively, compared with the sons and daughters of fathers without cancer. Thus, there were no differences in the relative risks of developing cancer among sons and daughters of fathers who had a history of cancer.
For genital cancers, the relative risks in offspring of fathers with genital cancers were 1.32 (95% CI: 1.12, 1.57) and 1.16 (95% CI: 0.96, 1.41) for sons (140 cases) and daughters (105 cases), respectively, compared with offspring of fathers without cancer. Among fathers with breast cancer (292 cases in total), none of their sons developed breast cancer, but the relative risk of breast cancer in their daughters (10 cases) was 5.96 (95% CI: 3.20, 11.1).
For mothers with cancer, cancers occurred in 2,854 sons and 3,259 daughters ( Because offspring were younger than their parents, we further examined risk among offspring of parents who developed cancer at less than 50 years of age, that is, in a similar age range (Table 2) . Excluding genital and breast cancers, the sons and daughters of fathers with cancer diagnosed before age 50 years had similarly increased relative risks of developing nongenital/nonbreast cancers (relative risk (RR) ¼ 1.23 (95% CI: 1.08, 1.41) and RR ¼ 1.32 (95% CI: 1.15, 1.52), respectively). Among offspring of women who developed nongenital/nonbreast cancers before age 50 years, the risks of nongenital/nonbreast cancer in both sons and daughters (RR ¼ 1.49 (95% CI: 1.32, 1.69) and RR ¼ 1.42 (95% CI: 1.24, 1.64), respectively) were higher than in the offspring of fathers who were diagnosed with cancer before age 50 years, but they did not differ in sons and daughters. When either parent was diagnosed with cancer at an older age, the relative risks in both sons and daughters were lower than those among offspring whose parents developed cancer before age 50 years, but risks were nevertheless still statistically increased and also similar in sons and daughters. Risks of developing the same cancer versus a different cancer in offspring of parents with cancer were analyzed using a competing-risks model (Table 3) . In this analysis, outcome was the first cancer diagnosis in the offspring. We used a competing-risks model in which similar and dissimilar cancers in the parent became exposures for each cancer type and obtained a common estimate for the risk of similar or dissimilar cancer in offspring, given the cancer history of the parent. Genital and breast cancers were excluded because of their specific genetic predilection between parent and offspring, as presented above. Both sons (168 cases) and daughters (117 cases) of fathers diagnosed with nongenital/ nonbreast cancer had increased relative risks of developing the same type of cancer as occurred in the father (RR ¼ 2.06 (95% CI: 1.77, 2.41) and RR ¼ 1.98 (95% CI: 1.65, 2.38), respectively). Similarly, among offspring of mothers with nongenital/nonbreast cancer, 172 sons and 141 daughters developed the same type of cancer, with the relative risks being 3.02 (95% CI: 2.59, 3.51) and 2.98 (95% CI: 2.52, 3.52), respectively. Again excluding breast/genital cancers, the relative risks for having cancers of different types were similarly increased for both sons and daughters of men with cancer (RR ¼ 1.08 (95% CI: 1.03, 1.14) and RR ¼ 1.09 (95% CI: 1.03, 1.16), respectively), whereas sons of mothers with cancer were at increased risk (RR ¼ 1.15, 95% CI: 1.10, 1.21) of developing different cancers but daughters were not (RR ¼ 1.01, 95% CI: 0.95, 1.07).
DISCUSSION
At almost every anatomic site other than the breast and genitalia, males had significantly higher cancer incidences than females, with only cancers of the thyroid and gallbladder and, at younger ages, melanoma being the exceptions. Even in childhood, when cancer risk is low, boys were significantly more at risk of overall cancer than girls, although the significance of this observation in children was driven largely by lymphoid malignancies, the most common tumors of childhood. Similar results were seen in data from Denmark and the United States. These higher risks in males are not new observations but are presented to emphasize the consistency of findings across diverse nongenital/nonbreast cancer types.
At nongenital/nonbreast sites, sons had more cancer than daughters, as expected from sex ratio data. For these cancers, offspring of parents with a cancer history had 14% greater cancer risks than offspring of parents without a cancer history. Offspring of parents who develop nongenital/nonbreast cancer at a young age (<50 years) had a higher risk of developing cancer at a young age than offspring of parents who developed cancer at an older age. These patterns could be due to genetic factors, but they could also be plausibly explained by environmental and lifestyle factors that are similar in 2 generations of the same family and affect cancer risk. For example, smoking by offspring is more likely when parents smoke (8, 9) , diets are likely to be similar, and offspring may be more likely to go into similar occupations.
Our specific aim in this study was to seek a parsimonious explanation for this sex difference in cancer risk. Cancer causation is rooted in DNA changes (10). While we acknowledge the dominant role of environmental carcinogens in causing DNA damage and malignant transformation, we hypothesized that sex differences in cancer incidences would be related to X-chromosome genes that affect the metabolism of carcinogens or their impact on the cell's genome. For example, DNA repair or apoptosis genes could affect responses to genotoxic environmental exposures (10) . Many genes on autosomal chromosomes are probably involved, but, for them, genetic heritance would presumably affect both sexes equally. However, for X chromosome genes, men and women differ in that males inherit only a single chromosome from their mother and all cells depend on the same X chromosome, whereas in females, cells can express either the paternal or the maternal X chromosome after X inactivation. We hypothesized that this biologic difference could explain a portion of the differences in cancer risk between the sexes. In undertaking this study, we deliberately examined groups of diverse cancers because the hypothesis anticipated finding a common effect in different types of cancer. Specifically, we proposed that the male haploid X chromosome might convey greater susceptibility to cancer in cells of diverse types, and thus partially explain the excess cancer risk in males. Because the male X chromosome is passed from a father to every daughter but none of his sons, we looked for differences in the offspring cancer risk when fathers had cancer. However, we did not find support for our hypothesis. Comparing risk ratios in the offspring of fathers with and without cancer histories, relative risks were similar in sons and daughters, even though only daughters received the father's X chromosome. We also examined risks of offspring developing cancers at different sites than their fathers, with the intent of limiting the impact of inherited risk at specific sites. Again, we observed no differences in risk of either all cancers or nongenital/nonbreast cancers between sons and daughters of fathers with cancer. Higher risks (2-fold) of developing the same type of cancer the father had had were observed in offspring.
Data on the offspring of mothers with and without cancer histories were examined as a control for the analytical method used. As expected, risk ratios in mothers' sons and daughters did not differ significantly at nongenital/ nonbreast sites. In analysis of the risk of developing nongenital/nonbreast cancers at different sites, given cancer in the mother, sons appeared to have a higher risk than daughters. Risks for developing the same type of nongenital/ nonbreast cancer were 3-fold higher in both sons and daughters of mothers with cancer. The higher risk in sons of mothers with cancer than in sons of fathers with cancer was unexpected. Perhaps it occurred by chance, or perhaps mothers have more influence on their sons' lifestyle choices than fathers. When the analysis was restricted to parents with cancer onset before age 50 years, the relative risks remained similar in sons and daughters of fathers who had cancer as well as the offspring of mothers who had cancer, again refuting our hypothesis of an X chromosome effect.
To complete analyses for all cancers, we also examined the risks of genital and breast cancer in these families. Although these cancers were not the focus of this study, some general observations are warranted. Our observations deliberately grouped genital cancers in order to gain statistical power, but other investigators have generally examined offspring risks for specific types of genital cancer. Hence, the relative risks we report are not entirely comparable to those from other studies. Since the offspring were aged 53 years or less, testicular cancer would probably have dominated the male genital cancer rates among sons. This cancer is recognized to have a familial component (11) (12) (13) (14) , which probably accounts for our increased risk of genital cancer in sons of fathers with a history of genital cancer. In females, types of genital cancer are more varied. However, among young women, familial risks have been reported for cancers of the uterus (14) (15) (16) (17) (18) (19) (20) as well as ovary (21, 22) , so it is not surprising that, in aggregate, genital cancer risks were increased in daughters of mothers who had genital cancer. In sons of mothers with genital cancer, the risk of genital cancer was not increased; this finding is in agreement with a previous Danish study of testicular cancer (11) , which had overlapping data. However, in daughters of fathers with genital cancer, female genital cancer risk was also marginally increased in our study. Similarly, other genital cancer risks were significantly increased in family members of men with testicular cancer (23) . If this association is confirmed elsewhere, it merits further exploration; but, as with other cancers, higher risks within families may be due to environmental as well as genetic reasons.
For breast cancer, a specific site, our observations are consistent with those of other reports. As in other studies (24, 25) , breast cancer risks were increased 2-fold in daughters of mothers with breast cancer. However, we found that risks in daughters of fathers with breast cancer and sons of mothers with breast cancer were both increased 5-to 6-fold. While increased risk for daughters of fathers with breast cancer have been also reported elsewhere (24) (25) (26) (27) (28) , our risk estimates were higher than those reported in other countries. For example, in Sweden, nonsignificant 1.8-fold increases were reported for both sons of mothers and daughters of fathers with breast cancer (24) , whereas our relative risks were approximately 5 and highly significant. However, our higher risk estimates agree with those of an earlier brief report from Denmark in which similarly high risks were found (28) . Inherited defects of the BRCA1 or BRCA2 gene contribute strongly to familial breast and ovarian cancer risks in the Scandinavian population (29, 30) , as elsewhere (31) . Although these genes are located on chromosomes 17 and 13, respectively, skewed inactivation of X chromosomes seen in carriers of BRCA mutations suggests that there may be functionally important interactions between BRCA genes and the X chromosome (1).
Statistically, rate ratios are indirect measures of risk, since risk is being measured relative to different background risks (i.e., sons of fathers with cancer against all males vs. daughters of fathers with cancer against all females). To the extent that background rates differed between males and females, the denominator will have affected the absolute measures of risk. However, the impact of using an indirect measure to compare risks should have been small, except at genital and breast sites, which were analyzed separately.
In summary, we could not explain the higher cancer risk in males by means of our X chromosome hypothesis. We found familial cancer risk patterns in Denmark to be generally similar to those reported elsewhere, with higher risks being observed in the offspring of parents with cancer, particularly when the parental cancer was diagnosed before the age of 50 years. Genital cancer risks were increased in daughters of mothers and sons of fathers with genital cancer, although the marginally increased risk in daughters of fathers with genital cancer may be of interest. Breast cancer risks were similarly high in daughters when either the father or the mother had had breast cancer, and sons of mothers with breast cancer had relatively higher risks than daughters, although the absolute risk in males was much lower. The higher cancer risks observed in the offspring of parents who have had cancer could be partly attributable to genetic influences, but offspring risks would also be affected by learned behaviors affecting their likelihood of exposure to environmental carcinogens.
